Page 97 - Read Online
P. 97
Page 86 Shu et al. Intell Robot 2024;4(1):74-86 I http://dx.doi.org/10.20517/ir.2024.05
Availability of data and materials
Not applicable.
Financial support and sponsorship
ThisworkissupportedbytheNationalNaturalScienceFoundationofChina(U1913208), ScienceandTechnol-
ogy Program of Tianjin (21JCZDJC00170), Tianjin Key Medical Discipline (Specialty) Construction Project
(TJYXZDXK052B), Tianjin Health Research Project (TWJ2022XK024), and Excellent Youth Team of Central
Universities (NKU63231196).
Conflicts of interest
All authors declared that there are no conflicts of interest.
Ethical approval and consent to participate
ThestudywasapprovedbythelocalethicscommitteeofTianjinHuanhuHospital(No. 2019-56)andregistered
in the Chinese Clinical Trial Registry (ChiCTR1900022655). The informed parental/caregiver consent was
obtained for all patients in accordance with the Declaration of Helsinki.
Consent for publication
Not applicable.
Copyright
© The Author(s) 2024.
REFERENCES
1. GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic
analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019;18:459–80. DOI
2. Qi S, Yin P, Wang L, et al. Prevalence of Parkinson’s disease: a community-based study in China. Mov Disord 2021;36:2940–4. DOI
3. Dorsey ER, Constantinescu R, Thompson JP, et al. Projected number of people with Parkinson disease in the most populous nations, 2005
through 2030. Neurology 2007;68:384–6. DOI
4. Jankovic J. Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008;79:368–76. DOI
5. Emamzadeh FN, Surguchov A. Parkinson’s disease: biomarkers, treatment, and risk factors. Front Neurosci 2018;12:612. DOI
6. Berardelli A, Rothwell JC, Thompson PD, Hallett M. Pathophysiology of bradykinesia in Parkinson’s disease. Brain 2001;124:2131–46.
DOI
7. Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 2015;30:1591–601. DOI
8. Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating
Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008;23:2129–70. DOI
9. Post B, Merkus MP, de Bie RMA, de Haan RJ, Speelman JD. Unified Parkinson’s disease rating scale motor examination: are ratings of
nurses, residents in neurology, and movement disorders specialists interchangeable? Mov Disord 2005;20:1577–84. DOI
10. Das S, Trutoiu L, Murai A, et al. Quantitative measurement of motor symptoms in Parkinson’s disease: a study with full-body motion
capture data. In: 2011 Annual International Conference of the IEEE Engineering in Medicine and Biology Society; 2011 Aug 30 - Sep
03; Boston, USA. IEEE; 2011. pp. 6789–92. DOI
11. Mentzel TQ, Mentzel CL, Mentzel SV, Lieverse R, Daanen HAM, van Harten PN. Instrumental assessment of bradykinesia: a comparison
between motor tasks. IEEE J Biomed Health Inform 2016;20:521–6. DOI
12. Zheng YL, Ding XR, Poon CCY, et al. Unobtrusive sensing and wearable devices for health informatics. IEEE Trans Biomed Eng
2014;61:1538–54. DOI
13. Kim JW, Lee JH, Kwon Y, et al. Quantification of bradykinesia during clinical finger taps using a gyrosensor in patients with Parkinson’s
disease. Med Biol Eng Comput 2011;49:365–71. DOI
14. Djurić-Jovičić M, Jovičić NS, Roby-Brami A, Popović MB, Kostić VS, Djordjević AR. Quantification of finger-tapping angle based on
wearable sensors. Sensors 2017;17:203. DOI
15. Patel S, Lorincz K, Hughes R, et al. Monitoring motor fluctuations in patients with Parkinson’s disease using wearable sensors. IEEE
Trans Inf Technol Biomed 2009;13:864–73. DOI
16. Wahid F, Begg RK, Hass CJ, Halgamuge S, Ackland DC. Classification of Parkinson’s disease gait using spatial-temporal gait features.
IEEE J Biomed Health Inform 2015;19:1794–802. DOI
17. Yin Z, Geraedts VJ, Wang Z, Contarino MF, Dibeklioglu H, van Gemert J. Assessment of Parkinson’s disease severity from videos using
